VERTEX PHARMACEUTICALS INC / MA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
VERTEX PHARMACEUTICALS INC / MA has filed 3,632 SEC EDGAR filings since 15 Feb 1995

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
4

FORM 4

Filing date
15 Nov 2023
Reporting date
13 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
15 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
15 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Nov 2023
Reporting date
06 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
06 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
31 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Oct 2023
Reporting date
17 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Oct 2023
Reporting date
17 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Oct 2023
Reporting date
16 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Oct 2023
Reporting date
13 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Oct 2023
Reporting date
13 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
16 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Oct 2023
Reporting date
06 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Oct 2023
Reporting date
05 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Oct 2023
Reporting date
05 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
06 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2023
Reporting date
03 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .